ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,708,498 | -10.4% | 95,128 | +1.4% | 0.00% | – |
| Q2 2023 | $1,907,770 | +35.5% | 93,794 | +44.9% | 0.00% | -100.0% |
| Q1 2023 | $1,408,351 | +32.7% | 64,722 | +89.0% | 0.00% | 0.0% |
| Q4 2022 | $1,061,253 | -41.5% | 34,245 | -51.9% | 0.00% | 0.0% |
| Q3 2022 | $1,814,000 | +116.2% | 71,122 | +72.0% | 0.00% | 0.0% |
| Q2 2022 | $839,000 | +254.0% | 41,343 | +330.8% | 0.00% | – |
| Q1 2022 | $237,000 | -82.1% | 9,597 | -74.8% | 0.00% | -100.0% |
| Q4 2021 | $1,321,000 | +115.8% | 38,024 | +68.6% | 0.00% | – |
| Q3 2021 | $612,000 | -69.2% | 22,550 | -70.6% | 0.00% | -100.0% |
| Q2 2021 | $1,986,000 | -19.3% | 76,578 | -32.9% | 0.00% | -50.0% |
| Q1 2021 | $2,460,000 | +1518.4% | 114,152 | +1511.0% | 0.00% | – |
| Q4 2020 | $152,000 | +133.8% | 7,086 | +60.9% | 0.00% | – |
| Q3 2020 | $65,000 | -90.7% | 4,405 | -86.0% | 0.00% | -100.0% |
| Q2 2020 | $700,000 | +3.4% | 31,364 | -34.6% | 0.00% | 0.0% |
| Q1 2020 | $677,000 | -41.2% | 47,982 | -32.3% | 0.00% | 0.0% |
| Q4 2019 | $1,151,000 | -40.9% | 70,832 | +27.1% | 0.00% | -50.0% |
| Q3 2019 | $1,949,000 | -29.9% | 55,717 | +13.0% | 0.00% | 0.0% |
| Q2 2019 | $2,782,000 | +1596.3% | 49,293 | +2088.9% | 0.00% | – |
| Q1 2019 | $164,000 | -97.8% | 2,252 | -98.1% | 0.00% | -100.0% |
| Q4 2018 | $7,535,000 | +42.5% | 118,132 | +123.0% | 0.01% | +40.0% |
| Q3 2018 | $5,286,000 | +45.5% | 52,982 | +3.6% | 0.01% | +66.7% |
| Q2 2018 | $3,632,000 | -60.6% | 51,123 | -42.2% | 0.00% | -62.5% |
| Q1 2018 | $9,212,000 | -31.5% | 88,505 | -33.7% | 0.01% | -27.3% |
| Q4 2017 | $13,448,000 | +213.8% | 133,518 | +8.9% | 0.01% | +175.0% |
| Q3 2017 | $4,286,000 | +9640.9% | 122,639 | +6522.0% | 0.00% | – |
| Q2 2017 | $44,000 | +1000.0% | 1,852 | +1222.9% | 0.00% | – |
| Q1 2017 | $4,000 | – | 140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |